World Mental Health Day 2025

World Mental Health Day 2025

Copenhagen, Denmark 

Each year on World Mental Health Day, we are reminded that mental health is a universal human right, one that deserves the same attention, care, and access as physical health.

Across the world, millions of people continue to face mental health challenges, yet access to quality care remains limited, and stigma persists. At Monsenso, we believe that digital innovation can help close this gap by making prevention, treatment, and self-management more accessible, personalised, and data-driven.

Empowering people through digital health

Through our innovation projects — including MentBest, PERSONAE, DECODE, and Smart-Bipolar — as well as our clinical implementations, we collaborate with partners across Europe to:

  • Improve access to mental health support through digital platforms
  • Empower individuals and families with real-time insights and self-management tools
  • Support clinicians with data-driven decision-making for timely and effective interventions

By combining technology, research, and collaboration, Monsenso aims to enable a more proactive and inclusive approach to mental health care. Digital tools can bridge the gap between individuals and professionals, promote early intervention, and ultimately improve outcomes for those affected by mental health conditions.

Our mission at Monsenso

At Monsenso, our mission is to improve mental health and wellbeing through digital innovation. We work to empower individuals, carers, and healthcare professionals by providing tools that support self-management, enhance communication, and enable data-driven care. By doing so, we strive to make mental health services more efficient, scalable, and person-centred — helping ensure that no one is left behind in accessing the support they need.

A shared mission for change

On this World Mental Health Day, we stand together with our partners and the global community in the mission to ensure that everyone, everywhere, has access to quality mental health care. Together, we can build a future where mental health is valued, supported, and protected for all.


To learn more or explore a pilot or integration, book a demo or get in touch via our website.

 

Missed Our Webinar on Digital Markers and Health Technology? Here Are the Key Takeaways

Missed Our Webinar on Digital Markers and Health Technology? Here Are the Key Takeaways

Copenhagen, Denmark 

On the 11th of June, we hosted our webinar Unlocking the Future of Mental and Behavioural Health with Digital Biomarkers and Health Technology. Our speakers, Maria Faurholt-Jepsen, Associate Professor and psychiatrist at the University of Copenhagen, and Emil Kortsen, Product Manager at Monsenso, explored how digital tools are transforming health research, monitoring, and treatment.

You can watch the full session on-demand here: view the recording.

From smartphone-based symptom tracking to AI-powered personalised care, here are the main takeaways:

1. Digital phenotyping is transforming mental health care

Smartphone-based solutions can collect both active (self-reported) and passive (sensor-derived) data. This fine-grained, real-time information provides clinicians with a more accurate picture of patient wellbeing, reducing reliance on memory and subjective observation.

2. Mood instability matters – and we can measure it

Longitudinal studies reveal that mood instability, especially in bipolar type II disorder, is more common and impactful than previously thought. Even between episodes, these fluctuations can significantly reduce quality of life, functioning, and resilience.

3. Passive data can detect symptom changes

Patterns in phone usage, mobility, and even voice features correlate strongly with depressive and manic states. For example, decreased movement and increased behavioural irregularity can distinguish bipolar from unipolar depression.

4. Clinical trials are integrating digital biomarkers

Ongoing trials are using daily monitoring to measure treatment response, ranging from medication effects to psychoeducation programmes. While some studies have not shown primary outcome changes, they have demonstrated benefits such as reduced stress, less rumination, and improved quality of life.

5. Personalised, stepped care is already here

The Personae Project uses digital tools to deliver customised treatment for depression. Based on validated questionnaires, it creates tailored therapy content and adjusts care intensity in real time depending on each patient’s progress.

6. Digital tools bridge psychiatric and physical healthcare

In the Phase V Project, digital monitoring is helping manage diabetic foot ulcers. Patients and home-care staff can submit wound assessments and photos to hospital specialists, enabling timely interventions and reducing unnecessary visits. Phase V also includes studies in obesity and urticaria.

7. Engagement thrives on relevance

Projects have achieved high compliance (often 75%+) when patients see real value in the system. Personalised recommendations, timely feedback, and flexibility to “hop on and off” monitoring are key to sustained use.

8. AI will power the next generation of digital care

From detecting symptom shifts to personalising interventions, AI is already being trialled in projects like MENTBEST and Personae. These tools aim to provide predictive insights while meeting strict ethical and data protection standards.

Join us next time

Don’t miss our next webinar: 2 September 2025 at 15:30 CEST – Personalised, Data-Driven Blended Care: Insights from the Personae Project.
Discover how personalised, data-driven care can transform outcomes across mental health services.

Register here


To learn more or explore a pilot or integration, book a demo or get in touch via our website.

 

Welcoming the NHS 10-Year Plan

Welcoming the NHS 10-Year Plan

Copenhagen, Denmark 

On July 3rd 2025, the UK Government published Fit for the Future: 10 Year Health Plan for England, outlining a bold, transformative vision to make the NHS sustainable, equitable, and technology-led for the next decade and beyond.

This plan hinges on three radical shifts:

  1. From hospital to community
  2. From analogue to digital
  3. From sickness to prevention

It emphasizes empowering patients, deploying predictive and preventive care, embracing wearables and AI, integrating care teams locally, and making NHS staff more effective and supported.

Monsenso celebrates these ambitions, and stands ready to support the NHS in delivering them.

How Monsenso Aligns with the NHS Vision

Hospital → Community: Local, continuous, personalised mental health support

The NHS aims to shift care into neighbourhood health centres and patients’ homes, creating continuous, integrated care pathways.

Monsenso’s digital health platform enables precisely this shift into remote patient monitoring. By combining self-reported symptom data with wearable sensor data, our system allows clinicians to monitor mental health remotely, detect early signs of deterioration, and intervene proactively, without waiting for hospital referrals.

Analogue → Digital: Empowered patients and data-driven care 

With the NHS committed to digital transformation, turning the NHS App into a full “front door”, Monsenso offers a complementary digital health tool that seamlessly integrates into clinicians’ workflows while putting patients in control of their day-to-day mental health management .

Our mobile apps support:

  • Electronic patient-reported outcomes (e-PROs)
  • Medication and appointment reminders
  • Psychoeducational content and self-help tools
  • Secure two-way messaging between patients and care teams

Clinicians gain access to actionable dashboards, analytics and predictive risk alerts; all in the cloud, accessible anytime, anywhere.

Sickness → Prevention: Early detection, digital prevention, value-based care

The NHS plan emphasises predictive care, with wearables becoming standard, and incentives for preventive interventions & value-based outcomes .

Monsenso supports predictive analytics and mood forecasting, drawing on real-world behavioural data to flag rising risk and support earlier intervention before crisis points. Campaigns like the ECoWeB CBT-based app trials – built on Monsenso’s platform – have demonstrated that sustained self-help interventions can prevent depression onset in high-risk youth across several countries. This aligns with the NHS’s focus on prevention, mental wellbeing in young people, and cost-effective scaling.

Supporting workforce, transparency & innovation

The NHS wants a workforce empowered through digital tools, and more transparency using patient-reported outcome measures and performance data. By providing clinicians with real-time insights into engagement, adherence, symptoms and outcomes, Monsenso reduces administrative burden, enables triage based on clinical risk, and supports shared decision-making with patients.

As a CE and UKCA-marked medical device, certified to ISO 27001, ISO 13485 and Cyber Essentials, Monsenso meets the UK and EU regulatory and digital compliance standards, and is ready to integrate within NHS quality, safety, and innovation frameworks.

Key Benefits for NHS Mental Health Services

NHS Priority Area How Monsenso Helps
Community-based care Enables remote monitoring, blended care and integration across primary, secondary and community settings
Digital access  A digital companion that could be aligned with NHS App ‘HealthStore’ pathways and services
Preventive mental health Predictive analytics, self-help interventions, early risk detection, and prevention of relapse or crisis
Patient empowerment & equity Inclusive tools for self-management, carers and diverse populations; scalable across regions
Workforce productivity Streamlines patient review, prioritises high-risk cases, reduces admin burden, freeing clinicians for care.

 

Championing Change with Monsenso

At Monsenso, our mission is to make mental healthcare more predictive, equitable, person-centred, and scalable – perfectly aligned with the NHS 10-Year Plan. Our digital health platform is already in use in multiple countries, supporting thousands of individuals living with conditions such as depression, bipolar disorder, anxiety, schizophrenia, and addiction. With high adherence rates and robust real-world evidence from research partnerships, we know digital tools can work at scale.

We’re ready to collaborate with NHS England, integrated care boards, neighbourhood health centres and mental health providers to deliver against key NHS targets – especially for youth mental health, the expansion of mental health in primary care and remote psychological support.

Looking Ahead

As the NHS embarks on its most transformative decade, Monsenso is poised to partner where technology, data-driven care and human-centred health practice converge. We look forward to supporting the NHS to make mental and somatic health support more accessible, effective and forward-looking – together.


To learn more or explore a pilot or integration, book a demo or get in touch via our website.

 

Denmark Completes 10-Year Plan for Psychiatry – Strengthening Mental Health for the Future

Denmark Completes 10-Year Plan for Psychiatry – Strengthening Mental Health for the Future

Copenhagen, Denmark 

The Danish Government has presented the final part of its comprehensive 10-year plan for psychiatry, a long-term initiative designed to secure better mental health services across the country. The new proposal builds on several years of investments and reforms and represents a turning point in how psychiatric care is organised and delivered in Denmark.

The plan’s ambition is clear: to ensure that all individuals living with mental health challenges can access timely, effective, and high-quality treatment, while also receiving support that enables them to thrive in everyday life.

Key elements of the plan include:

  • Earlier intervention and prevention: Strengthening outreach and ensuring that signs of mental illness are detected and addressed sooner.

  • More treatment capacity: Expanding resources in both child & adolescent psychiatry and adult psychiatry to meet rising demand.

  • Cross-sector collaboration: Closer integration between psychiatry, primary care, social services, and education, ensuring patients receive coordinated support across systems.

  • Focus on recovery and everyday life: Shifting attention from acute treatment alone to also supporting long-term recovery, rehabilitation, and reintegration into school, work, and community.

  • Better access and reduced inequality: Targeting efforts to ensure equal access to psychiatric services regardless of geography, social background, or economic status.

The plan underlines that psychiatry is not only a medical challenge but a societal one. Mental health must be supported not just in hospitals and clinics, but also in schools, workplaces, families, and communities.

How Monsenso Contributes

At Monsenso, we strongly welcome the government’s continued prioritisation of psychiatry. The principles set out in the 10-year plan align closely with our mission to empower individuals, clinicians, and healthcare systems through digital innovation.

Our digital health platform is already supporting psychiatric care across Denmark and internationally, and can help realise several of the government’s ambitions:

  • Early detection and intervention
    By capturing real-time patient-reported outcomes and digital biomarkers, the Monsenso solution helps clinicians identify changes in symptoms at an earlier stage. This enables timely support and prevents conditions from escalating.

  • Strengthening cross-sector collaboration
    The platform facilitates secure data sharing and communication between patients, relatives, and care teams across healthcare sectors. This ensures that information follows the patient, promoting coordinated treatment pathways.

  • Supporting recovery in everyday life
    Our mobile app empowers individuals to actively engage in their own treatment, track progress, and access coping strategies directly from home. This helps extend care beyond the clinic, improving continuity and supporting long-term recovery.

  • Promoting equality and accessibility
    Digital tools can help reduce geographic and social disparities by making care more accessible, particularly for those in remote areas or with limited ability to attend frequent in-person consultations.

    Building the Psychiatry of the Future

    The Danish Government’s 10-year plan for psychiatry represents a historic opportunity to strengthen mental health services for generations to come. Achieving these goals will require both systemic reforms and innovative technologies that can bridge the gap between patients’ daily lives and the healthcare system.

    Monsenso is proud to contribute to this transformation. For example, through PhaseV, a national innovation programme supported by Innovation Fund Denmark, Monsenso provides the digital backbone for decentralised, real-world clinical studies, including within psychiatry. By enabling patients to share daily health data from home and giving clinicians access to these insights in real time, the project demonstrates how digital tools can strengthen early intervention, improve patient engagement, and extend care beyond traditional settings.

    Beyond Denmark, Monsenso also contributes at the European level through projects such as Personae (developing blended care models for mental health) and MentBest (creating digital tools to prevent common mental disorders). Together, these initiatives highlight how digital innovation can support more patient-centred, proactive, and sustainable mental health systems — both nationally and internationally.


    To learn more or explore a pilot or integration, book a demo or get in touch via our website.

     

    Monsenso Implements The Shape Up Method

    Monsenso Implements The Shape Up Method

    Monsenso has moved on from Scrum and are now using The Shape Up Method. This has meant changes …. in a good way.

    With Shape Up we focus on an appetite and cycles instead of focusing on sprints and estimates. Some will say same, same, but we believe there is a difference.

    The appetite for a project defines the length of a cycle. This means that we work on narrowing down the problem and designing the outline of a solution that fits within the constraints of our appetite.

    With this approach, time is fixed, but scope is variable. Cycles are long enough to build something meaningful start-to-finish and short enough that everyone can feel the deadline looming from the start, so the time is spent wisely.

    The method consist of three major parts: Shaping, Betting and Building.
    The work is shaped prior to starting a cycle. Shaping results in a Pitch, which outlines the problem and the solution, as well as no-gos and possible rabbit holes. The pitch is concrete enough that the team know what to do, yet abstract enough that there is room to work out the interesting details themselves.

    Next, the pitches are brought to the Betting table, where it is decided what pitches should be worked on in the forthcoming cycle. This is the only official meeting within the Shape Up method, which is a plus according to our developing team.

    “One meeting in the shape up method – the Betting Table – which means there’s no unnecessary meetings. Meetings, which would otherwise take time away from actual development.”

    Then the Building begins. Here, full responsibility is given to the team. They define their own tasks, make adjustments to the scope, and work together to build vertical slices of the product one at a time.

    With Shape Up, we all work towards a common goal within a cycle. The development team brings the rest of the company along for the ride, as they demo their work during the cycle. This way, every employee is updated on the work being done, and everyone has a chance to give feedback. With this, everyone gets to be a part of the process. This has brought the team closer to the product and closer together.

    The results so far: the organisation has been brought closer to the product and closer together and the speed with which we are producing usable features for our customers has significantly increased. We are learning everyday and believe there is still a lot of things we can improve using Shape Up.

    If this sounds like something, you want to be a part of, apply for a spot on our team as a Software Developer.

    You can find the job post here.

    For more information about the Shape Up method, you can check out this podcast from the company, who invented the method, 37signals.

    They also have a free book on the method, which you can check out here.

    Healthcare as a business case: Which importance is placed on societal impact vs economic impact?

    Healthcare as a business case: Which importance is placed on societal impact vs economic impact?

    Over the past decade, public spending on health in Denmark has been above the EU average. Due to the COVID-19 pandemic, government spending on healthcare has grown by more than 5% in 2020 alone [1], reaching total healthcare expenditures of DKK 270.794m in 2021 [2]. But how does Denmark decide which new treatment approaches to spend money on, and does the societal impact of healthcare measures play an equally important role as their economic impact?

    Though member states of the European Union are not precluded from “releasing marketing authorisations valid at national level” for new medicines/treatments, EU-wide marketing authorisations require new treatments to go through a centralised authorisation procedure managed by the European Medicines Agency (EMA), which evaluates the pharmaceutical quality, safety, and efficacy of new treatments [3]. However, whereas obtaining marketing authorisation on an EU level allows providers to offer their new medicines/treatments, it is mainly the national health authorities’ decisions on reimbursement and pricing measures that affect if patients will have access to them [3]. 

    In Denmark, the Danish Medicines Council (Medicinrådet) is an important body that assesses new treatment approaches and makes recommendations related to which medicines/treatments should be used in the Danish healthcare system [4]. Typically, cost-effectiveness and the impact on the healthcare budget are two important economic factors that national health authorities consider during such evaluations [3]. But what about the societal impact of new treatments? Does it receive sufficient consideration during the assessment procedures? 

    Let’s take innovative digital health solutions as an example. If we purely consider the direct economic costs digital health solutions for mental health can help to reduce, such as the costs for (re)hospitalisation (e.g., DKK 6.000 per day), do we really get a full picture of the value of these innovations in healthcare? Potentially not, as the societal impact would not have been considered.

    For instance, we would have not taken into account that digital health solutions for mental health can significantly improve the quality of life of individuals suffering from mental disorders [5], or that these innovations can enable mentally ill individuals to better recover and return to work faster. Neither would we have considered that digital solutions can facilitate making better use of resources available in the future, for instance by helping clinicians to handle growing patient data volumes they often feel overwhelmed with [6]. 

    The societal impact of new treatments may be more difficult to quantify than the pure health economic impact, but we believe it is an important factor to consider when evaluating innovative approaches. At Monsenso, we have made it our mission to enable better mental health for more people at lower costs, and the positive societal impacts and increased quality of life that we help generate are as important to us as the pure health economic impact.
    ——————————————————————————————————————————-
    About Monsenso
    Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence, and behavioural data. It connects individuals, carers, and healthcare providers to enable personalised treatment, remote care, and early intervention. We collaborate with health and social care, pharmaceuticals, and leading researcher worldwide in our endeavors to deliver solutions that fit into the life of patients and healthcare professionals. To learn more visit  www.monsenso.com

    References: 

    [1] European Commission (2021). State of Health in the EU · Denmark · Country Health Profile 2021.
    https://eurohealthobservatory.who.int/docs/librariesprovider3/country-health-profiles/chp2021pdf/denmark-countryhealthprofile2021.pdf?sfvrsn=e79f1c55_7&download=true

    [2] Statistics Denmark (n.d.). Health care expenditure.
    https://www.dst.dk/en/Statistik/emner/oekonomi/offentlig-oekonomi/udgifter-til-sundhed

    [3] European Parliament (2015). Towards a Harmonised EU Assessment of the Added Therapeutic Value of Medicines.
    https://www.europarl.europa.eu/RegData/etudes/STUD/2015/542219/IPOL_STU(2015)542219_EN.pdf

    [4] Medicinrådet (n.d.). Danish Medicines Council.
    https://medicinraadet.dk/om-os/in-english

    [5] Monsenso (2022). Key research findings.
    https://www.monsenso.com/wp-content/uploads/2022/06/Monsenso-Key-Research-Findings.pdf

    [6] Elsevier Health (2022). Clinician of the Future Report 2022.
    https://www.elsevier.com/connect/clinician-of-the-future